In particular, mutations in NF-κB inducing kinase (NIK), TRAF3, TRAF2, and cellular inhibitors of apoptosis 1 and 2 (cIAP1, cIAP2) are highly associated with human multiple myeloma (MM) and MM-derived cell lines. The gene discussed is BIRC2; the disease is Miyoshi myopathy.